US EditionPublished • loading... • Updated
AstraZeneca beats third-quarter expectations, maintains outlook
Summary by Business Times
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Merca2.esReposted by 
economiadigital.es
economiadigital.esAstraZeneca has presented the results corresponding to the first nine months of the year, in which it stands out an 11% increase in total income, reaching 43,236 million dollars. In addition, the third quarter, has closed with revenues of 15,191 million dollars, also with an increase of 12% compared to the same period of the previous year. Results that are driven by growth in all therapeutic areas. Specifically, it has been especially highlighte…
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
